Sort
85,873 grants matching “alzheimers”
MOUSE BIRN
$2,345,830Arthur W Toga · University Of California Los Angeles · U24 · FY2007 · RR
Mouse BIRN
$2,345,830Arthur W Toga · University Of California Los Angeles · U24 · FY2007 · RR
STAT3 activation in astrocytes as a driver of neurovascular dysfunction in Alzheimer's disease and related dementias
$2,345,579Ethan Lippmann · Vanderbilt University · RF1 · FY2022 · NS
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
$2,345,480Barbara L Hempstead · Weill Medical Coll Of Cornell Univ · RF1 · FY2023 · AG
Neural mechanism of spatial navigation and memory
$2,345,358Yi Gu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Disease Model Development and Phenotyping Project
$2,345,210Gareth R Howell · Indiana University Indianapolis · U54 · FY2019 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study
$2,345,103Reisa A. Sperling · Massachusetts General Hospital · P01 · FY2015 · AG
Brain-muscle microphysiological system enabled extracellular vesicle network for understanding aging in space
$2,344,810Mei He · University Of Florida · UG3 · FY2025 · TR
KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology
$2,344,572Andrew J Saykin · Indiana University Indianapolis · U01 · FY2023 · AG
Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related Dementia
$2,344,291Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · RF1 · FY2023 · NS
Systems Modeling of Alzheimers Disease in C. elegans
$2,344,012Yousin Suh · Albert Einstein College Of Medicine, Inc · RF1 · FY2017 · AG
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
$2,344,010Brent Peter Forester · Mclean Hospital · R01 · FY2020 · AG
Claudin Expression Profiles and Blood Brain Barrier in Aging
$2,343,371Anuska V Andjelkovic-Zochowska · University Of Michigan At Ann Arbor · RF1 · FY2017 · AG
DEploying High ValuE LOngitudinal Population-Based dAta in Dementia Research (DEVELOP AD Research)
$2,342,501R. Sean Morrison · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · AG
Adverse Cerebrovascular Responses to Antibodies Targeting Beta-Amyloid
$2,342,415David Hastings Cribbs · University Of California-Irvine · RF1 · FY2024 · NS
Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments
$2,342,002Rong Xu · Case Western Reserve University · RF1 · FY2022 · AG
Computational and Circuit Mechanisms Underlying Rapid Learning
$2,341,756Elizabeth A Buffalo · University Of Washington · U19 · FY2019 · NS
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
$2,341,700Brent Peter Forester · Mclean Hospital · R01 · FY2019 · AG
Einstein Aging Study
$2,341,020Albert Einstein Col Of Med Yeshiva Univ · P01 · FY2005 · AG
Pharmaceutical Research Center
$2,340,738Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2012 · MD
The VETSA Longitudinal MRI Twin Study of Aging
$2,340,303William S Kremen · University Of California, San Diego · R01 · FY2015 · AG
Using AI on Routine Clinical and Imaging Data from Acute Stroke Encounter to Predict Post-Stroke Vascular Contributions to Cognitive Impairment (AI - RESPECT)
$2,340,263Xiao Hu · Emory University · RF1 · FY2024 · NS
Longitudinal Imaging Biomarkers of Prodromal DLB
$2,340,234Kejal Kantarci · Mayo Clinic Rochester · U01 · FY2025 · NS
Knockin mouse models of Alzheimer's Disease
$2,340,048Hui Zheng · Baylor College Of Medicine · RF1 · FY2022 · AG
US POINTER Neuroimaging Ancillary Study
$2,339,411Susan M Landau · University Of California Berkeley · R01 · FY2025 · AG